ICNA PRESIDENT-ELECT ELECTIONS 2024

ICNA President-Elect Elections 2024 are currently underway. All eligible voters (ICNA Full Members) have been emailed their unique voting credentials. All voting is done via the secure platform at https://icnapedia.org/pe2024. The voting site will remain open until 2400hrs GMT on 1 May 2024.

Write a comment
Recent therapeutic advances in neuromuscular disorders

Recent therapeutic advances in neuromuscular disorders

Hot
 
0.0
 
0.0 (0)
0 2 0 0 2
ICNA
Updated

Webinars

Speaker
  • J Andoni Urtizberea
March 04, 2021
Series
ICNTN-AIIMS-COE
Language
English
Cost
Free
CPD/CME Credits

Prof. J Andoni Urtizberea MD
Attending Physician, APHP, HENDAYE, FRANCE
Head, Summer School of Myology, PARIS, FRANCE
Chargé de Mission, FILNEMUS, MARSEILLE, FRANCE

About the speaker

J. Andoni URTIZBEREA, (MD, MSc) is certified in paediatrics and PMR (physical medicine and rehabilitation) from Paris University, France. He also graduated from the Institut d’Etudes Politiques de Paris in 1987 cum magna laude. As Scientific Director of the European Neuromuscular Center (ENMC) and former Medical Director of the AFM-Telethon (the French MDA), he contributed to the establishment of many worldwide networks in myology, an emerging discipline dedicated to muscle and related disorders.

He is currently a part-time clinical myologist in Hendaye, south of France (Hôpital Marin, APHP), deputy coordinator of the French Neuromuscular Network (FILNEMUS) in Marseilles and member of the Executive Board of the TREAT-NMD Alliance.

Over the past twenty years, he headed various worldwide educational events dedicated to myology (in France, Russia, Latin America and, more recently in the Middle-East). He is a regular visiting professor for the Ministry of Health of Kuwait and a consultant for many pharmas involved in the field.

Ideally placed at the intersection of industry, patient advocacy groups and academics, his main objective is to raise more awareness about these rare conditions notably in emerging countries and more specifically in the context of novel cutting-edge therapies.

Viewer Review

No viewer reviews
Already have an account? or Create an account
Say something here...
Log in with ( Sign Up ? )
or post as a guest
Loading comment... The comment will be refreshed after 00:00.

Be the first to comment.